ReviewMaterials today. Bio2025
Engineering plasmonic Au nanostars: Enhanced plasmonic properties, preparation and biomedical application.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Article
- Emerging Plasmonic Nanomaterials for SERS-Based Disease Diagnostics: Innovations, Clinical Challenges, and AI Integration.Molecules (Basel, Switzerland) · 2026Review
- Non-enzymatic dual-mode plasmonic framework for robust bioanalyte detection.Scientific reports · 2026Article
- Oxidative Stress-Guided Gold Nanoparticles for Cancer Theranostics.Antioxidants (Basel, Switzerland) · 2026Review
- Application Advances of Gold Nanoparticles in Cancer Theranostics: From Physicochemical Mechanisms to Multifunctional Nanoplatforms.International journal of molecular sciences · 2026Review
- Gold bipyramids as a promising alternative to gold nanorods for analytical and biomedical applications.Beilstein journal of nanotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The anisotropic Au nanostars exhibit superior local electric field enhancement than their counterparts. Their longitudinal localized surface plasmon resonance (LSPR) wavelengths can be adjusted from visible to near infrared regions through morphological control. This review systematically synthesizes recent advances in star-shaped plasmonic nanoparticles, focusing on structure-property relationships and applications. A structured literature survey was conducted by screening peer-reviewed publications from databases period 2003-2025. The key insights include the defined classification frameworks of Au nanostars emphasizing three distinct nanostructures (fractal, hollow, and hybrid nanostructure), critical evaluation on the synthesis strategies and structural-property relationships of Au nanostars, applications in sensing and diagnostic, therapeutic application, and finally identification critical knowledge gaps and future research directions. These applications highlight the potential of Au nanostars in various biomedical and analytical fields. Despite significant progress, clinical translation remains challenging. The perspectives mainly include theoretical calculations, theoretical models, standardized preparation methods, and multi-stimuli responsive systems. We underscore the transformative potential of Au nanostars while highlighting the necessity for interdisciplinary collaboration to bridge existing gaps, provide some inspiration to develop novel functional nanomaterials with enhanced performance and ultimately accelerate their clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.